Genexine, Inc. – Trademark Portfolio
Entity Type: 98
Genexine, Inc. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include EFESA, FIDVAXI, OPTIDART, PAPITROL, and CERVICURA.
(Magokdong, Bio Innovation Park) 172,
Magokjungang-ro, Gangseo-gu Seoul 07789
Showing of trademarks Trademarks
Trademark Classifications
Genexine, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Genexine, Inc. have?
Genexine, Inc. has 16 U.S. trademarks filed with the USPTO. Of these, 7 registered, 4 abandoned, 2 cancelled.
What trademark classes does Genexine, Inc. file in?
Genexine, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Genexine, Inc.'s most well-known trademarks?
Genexine, Inc.'s registered trademark portfolio includes well-known marks such as EFESA, FIDVAXI, OPTIDART, PAPITROL, and CERVICURA. These are among 7 currently registered trademarks in the portfolio.
What is Genexine, Inc.'s trademark registration success rate?
Genexine, Inc. has a 54% trademark registration rate, with 7 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.